Skip to main content
Clinical Trials/NCT01094106
NCT01094106
Completed
Phase 4

Local Infiltration Analgesia for Postoperative Pain After Caesarean Section. A Prospective, Randomised, Controlled Trial

North Karelia Central Hospital1 site in 1 country70 target enrollmentApril 2010

Overview

Phase
Phase 4
Intervention
Ropivacaine 0,75%
Conditions
Pain, Postoperative
Sponsor
North Karelia Central Hospital
Enrollment
70
Locations
1
Primary Endpoint
The Demand of Rescue Analgesics (Oxycodone)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Infiltration of a local anesthetic into the surgical wound is a simple method to strive to control postoperative pain after surgery. In the investigators institution, this method is used quite often. However, there is a controversy regarding the analgesic efficacy. Moreover, the cost of the single use elastomeric pump used with this procedure is clearly higher than the costs of other routinely used analgesic methods.

According to the investigators observations, infiltration of a local anesthetic into the surgical wound after caesarean section seems to reduce the need for rescue analgesics. However, the scientific evidence of the efficacy of this technique is weak. The investigators decided to conduct a prospective, controlled, randomised, double blind trial on this topic.

The hypothesis is that wound infiltration with local anesthetic will reduce postoperative pain and opioid consumption after caesarean section without major adverse effects.

Registry
clinicaltrials.gov
Start Date
April 2010
End Date
October 2011
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
North Karelia Central Hospital
Responsible Party
Principal Investigator
Principal Investigator

Sanna Kouhia

MD

North Karelia Central Hospital

Eligibility Criteria

Inclusion Criteria

  • volunteer
  • age over 18 years
  • spinal anesthesia
  • no allergy to used medications
  • no medications which have effect on pain perception

Exclusion Criteria

  • patient's refusal to participate
  • marked systemic disease

Arms & Interventions

Ropivacaine 0,75%

Postoperative wound infusion 15 mg /h / 48h

Intervention: Ropivacaine 0,75%

NaCl 0,9%

Postoperative wound infusion with NaCl 0,9% 2 ml /h /48h

Intervention: NaCl 0,9%

Outcomes

Primary Outcomes

The Demand of Rescue Analgesics (Oxycodone)

Time Frame: 48 hours

The amount of oxycodone required 48 hours after operation. Oxycodone was administered when the strength of pain is over 3 on numeric rating scale (NRS) 0-10.

Secondary Outcomes

  • Strength of Pain on Numerical Rating Scale (NRS)(48 hours, divided to five time intervals (0-6 h, 6-12 h, 12-24 h, 24-36 h and 36-48 h))
  • Postoperative Nausea and Vomiting (PONV)(48 hours)

Study Sites (1)

Loading locations...

Similar Trials